BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33491812)

  • 1. Masquerading of COVID-19 Infection as Primary Mediastinal Large B-Cell Lymphoma.
    Bolaman AZ; Selim C; Karaman C; Yavaşoğlu İ
    Turk J Haematol; 2021 Feb; 38(1):77-78. PubMed ID: 33491812
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case.
    Yönal-Hindilerden İ; Hindilerden F; Arslan S; Doğan İÖ; Nalçacı M
    Turk J Haematol; 2018 May; 35(2):141-142. PubMed ID: 27094863
    [No Abstract]   [Full Text] [Related]  

  • 3. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
    Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
    Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Lymphoma of Liver-a Rare Space-Occupying Lesion.
    Patkar S; Dutt K; Shah A; Sengar M; Goel M
    J Gastrointest Cancer; 2020 Sep; 51(3):1057-1060. PubMed ID: 32333249
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated Lymphoma Evolving into Neurolymphomatosis during Mid-cycle of Chemotherapy Detected by (18)F-FDG PET/CT.
    Tong AK; Neo SH; Kok TY
    Ann Acad Med Singap; 2015 Nov; 44(11):545-7. PubMed ID: 27089963
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary mediastinal large B-cell lymphoma in an HIV-infected patient.
    Milling DL; Lazarchick J; Chaudhary UB
    Am J Med Sci; 2005 Mar; 329(3):136-8. PubMed ID: 15767818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients.
    Tai WM; Quah D; Yap SP; Tan SH; Tang T; Tay KW; Koo YX; Tao M; Quek R; Lim ST
    Leuk Lymphoma; 2011 Apr; 52(4):604-12. PubMed ID: 21261504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab maintenance therapy in diffuse large B-cell lymphoma: is XY the most important variable?
    Lunning MA; Armitage JO
    Haematologica; 2015 Jul; 100(7):853-5. PubMed ID: 26130511
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
    Dunleavy K; Fanale MA; Abramson JS; Noy A; Caimi PF; Pittaluga S; Parekh S; Lacasce A; Hayslip JW; Jagadeesh D; Nagpal S; Lechowicz MJ; Gaur R; Lucas A; Melani C; Roschewski M; Steinberg SM; Jaffe ES; Kahl B; Friedberg JW; Little RF; Bartlett NL; Wilson WH
    Lancet Haematol; 2018 Dec; 5(12):e609-e617. PubMed ID: 30501868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
    Vassilakopoulos TP; Papageorgiou SG; Angelopoulou MK; Chatziioannou S; Prassopoulos V; Karakatsanis S; Arapaki M; Mellios Z; Sachanas S; Kalpadakis C; Katodritou E; Leonidopoulou T; Kotsianidis I; Hatzimichael E; Kotsopoulou M; Dimou M; Variamis E; Boutsis D; Terpos E; Michali E; Karianakis G; Tsirkinidis P; Vadikolia C; Poziopoulos C; Pigaditou A; Vrakidou E; Siakantaris MP; Kyrtsonis MC; Symeonidis A; Anargyrou K; Papaioannou M; Chatziharissi E; Vervessou E; Tsirogianni M; Palassopoulou M; Gainaru G; Mainta C; Tsirigotis P; Assimakopoulou T; Konstantinidou P; Papadaki H; Dimopoulos MA; Pappa V; Karmiris T; Roussou P; Datseris I; Panayiotidis P; Konstantopoulos K; Pangalis GA; Rondogianni P
    Ann Hematol; 2021 Sep; 100(9):2279-2292. PubMed ID: 33523289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma.
    Knörr F; Zimmermann M; Attarbaschi A; Kabíčková E; Maecker-Kolhoff B; Ruf S; Kühnle I; Ebinger M; Garthe AK; Simonitsch-Klupp I; Oschlies I; Klapper W; Burkhardt B; Woessmann W
    Haematologica; 2021 Dec; 106(12):3232-3235. PubMed ID: 34498443
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?
    Lakhotia R; Melani C; Roschewski M; Wilson WH
    J Clin Oncol; 2022 Jun; 40(18):2063-2064. PubMed ID: 35377729
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary mediastinal large B-cell lymphoma.
    Ergul SM; Lal A; Afri L; Frei-Lahr D
    South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary renal lymphoma.
    Omer HA; Hussein MR
    Nephrology (Carlton); 2007 Jun; 12(3):314-5. PubMed ID: 17498130
    [No Abstract]   [Full Text] [Related]  

  • 16. DLBCL developed into fatal liver failure during rituximab-containing chemotherapy.
    Shimazu Y; Nohgawa M
    J Clin Exp Hematop; 2019; 59(2):93-95. PubMed ID: 31257349
    [No Abstract]   [Full Text] [Related]  

  • 17. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
    George A; Tam CS; Seymour JF
    Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma.
    Kilani Y; Sohail H; Lim CY; Payette A; Kamal SAF; Afzal A; Khan T; Paracha N; Muppidi MR; Sittler D
    Am J Case Rep; 2022 Sep; 23():e937500. PubMed ID: 36151707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy.
    Kim KM; Yoon DH; Lee SG; Lim SN; Sug LJ; Huh J; Suh C
    J Korean Med Sci; 2009 Jun; 24(3):525-8. PubMed ID: 19543522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
    Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
    J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.